Status:
UNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases
Lead Sponsor:
Hillel Yaffe Medical Center
Collaborating Sponsors:
Technion, Israel Institute of Technology
Conditions:
Retinitis Pigmentosa
Eligibility:
All Genders
Brief Summary
Retinitis Pigmentosa (RP) is the most common form of hereditary retinal degeneration, with a worldwide prevalence of 1:3500. It is one of the most genetically heterogenous conditions in humans, with o...
Detailed Description
Background: Retinitis Pigmentosa (RP) is a clinically and genetically heterogeneous disease, which causes visual loss due to the premature death of retinal photoreceptors. Over 100 genes and loci have...
Eligibility Criteria
Inclusion
- Patients with RP in which the genetic cause has not been identified yet and their healthy family members
Exclusion
- Patients with RP in which the genetic cause has already been identified
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02309866
Start Date
January 1 2015
End Date
January 1 2018
Last Update
December 5 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.